Zodwa Dlamini (biochemist)
Zodwa Dlamini is a South African biochemist and Ex-deputy Vice Chancellor for Research at the Mangosuthu University of Technology. She researches molecular oncology. She is a former Vice President of the South African Medical Research Council and is a member of the Council for Scientific Advisers for the International Centre for Genetic Engineering and Biotechnology. Early life and educationDlamini was born in the KwaZulu-Natal North Coast.[1] She worked as an administration clerk in provincial health before starting a degree in pharmacy.[2] She was not happy, and switched to Biochemistry and Microbiology, earning Bachelor's degrees at the University of the Western Cape.[2] She moved to the University of Natal for her Master's and PhD.[citation needed] CareerAfter her PhD, Dlamini returned to the University of the Western Cape as a postdoctoral fellow in molecular oncology.[3] In 2002 she joined the University of the Witwatersrand, where she studied the toxicity of traditional African beer.[2][4] In 2007 she was awarded a National Cancer Institute investigator opportunity award.[5] She joined the University of Limpopo as an associate professor in 2014.[6] She was appointed the lead of the research directorate at the Mangosuthu University of Technology in 2015.[7] In July 2017 Dlamini was confirmed as a member of the Council for Scientific Advisers for the International Centre for Genetic Engineering and Biotechnology.[3] She is a visiting professor at the University of Bristol.[8] Dlamini is concerned about education within the local community and supports schools in accounting, maths and physics.[9] She believes that Mangosuthu University of Technology can improve the lives of the people in Umlazi.[2] She is a member of the steering committee of the Academy of Science of South Africa's STEM education group.[5] In 2017 she led a delegation of Mangosuthu University of Technology scientists to the Dublin Institute of Technology.[10] She is interested in precision medicine. Dlamini has contributed to two books about cancer, including Current Immunotherapeutic Treatments in Colon Cancer and South African Herbal Extracts as Potential Chemopreventive Agents: Screening for Anticancer Splicing Activity.[11][12] Her current research looks at abnormal MicroRNA in cancers associated with HIV.[13] The project received R6 million over three years from the South African Medical Research Council.[13] References
|